No Data
No Data
GMO-FG, Kringler and others
<166A> Taski HD increases dividends, with this period's year-end dividends per share at 16.00 yen ← 15.00 yen <2342> Trans GG revises performance financial estimates, this period's operating profit forecast -0.11 billion yen ← 0.35 billion yen, dividend estimate revised, year-end dividends canceled <4051> GMO-FG increases dividends, previous period's year-end dividends per share at 62.00 yen ← 52.00 yen <4168> Yapuri revises performance financial estimates, this period's operating profit forecast 0.55 billion yen ← 0.5 billion yen <4583> Kaiom revises performance financial estimates, this period's revenue forecast 6.00
Chiome Bioscience Revises Forecast Amid Financial Challenges
Chiome Bioscience: Financial results supplementary materials 3rd quarter of the fiscal year ending 2024/12
Chiome Bioscience: Notice regarding the recording of non-operating expenses and revisions to earnings forecasts
Chiome Bioscience: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Chiome Bioscience 9-Mos Parent Loss Y915.00M Vs Loss Y918.00M
No Data
No Data